News & Events

Registration now open! Register now and join our 3rd webinar of the Advanced Therapeutics series. In this webinar, we will be focusing on Ocular Gene Therapy, the first in vivo gene therapy approved by the Therapeutic Goods Administration (TGA) here in Australia for clinical use in inherited retinal diseases. Inherited retinal diseases are a group of conditions that disproportionately affect c...

World Purple Day is celebrated on the 26th March, a day aimed at raising awareness of epilepsy. What is Epilepsy? Epilepsy is one of the most common neurological disorder that affects the brain, often causing seizures. Around 65 million people in the world have epilepsy and although epilepsy can develop at any stage of life, it is more common in children, adolescents and people over 60....

Missed out on our first webinar of the year? Watch the video of this webinar to hear from two esteemed leaders in the field of paediatric cancer and pioneers in CAR-T cell therapy. Chimeric Antigen Receptor (CAR) T cell therapy is the most therapeutic advancement in acute lymphoblastic leukaemia for generations and is a new form of immunotherapy approach to cancer. The CAR-T cell therapy appro...

We are back with our series of webinars which explores the way Advanced Therapeutics is driving clinicians and researchers to prepare for a new wave of therapies, revolutionising the future of paediatric health care. Register now and hear from two esteemed leaders in the field of paediatric cancer and pioneers in CAR-T cell therapy. Chimeric Antigen Receptor (CAR) T cell therapy is the most th...